NICE will have to approve all one-off interventions as life expectancy increases
What to do when quality-adjusted life years could mean many, many years?
Join the club for FREE to access the whole archive and other member benefits.
This institution provides national guidance and advice to improve health and social care
NICE's role is to improve outcomes for people using the NHS and other public health and social care services. We do this by:
- Producing evidence-based guidance and advice for health, public health and social care practitioners.
- Developing quality standards and performance metrics for those providing and commissioning health, public health and social care services.
- Providing a range of information services for commissioners, practitioners and managers across the spectrum of health and social care.
Visit website: https://www.nice.org.uk/
NationalInstituteforHealthandCareExcellence
national-institute-for-health-and-clinical-excellence
Details last updated 12-Nov-2019
What to do when quality-adjusted life years could mean many, many years?
Senior Scientific Adviser at NICE and Honorary Senior Research Fellow at Keele University
Deputy Chief Executive and Director of CHTE at NICE - National Institute for Health and Care Excellence
The drug 'donanemab' remains available for private treatment in England
New technology aims to improve diagnosis speed and accuracy in busy emergency departments
Technology automates insulin delivery, offering better blood sugar control
Portable Produodopa pump delivers steady medication, offering ease & relief for Parkinson's sufferers
Cutting-edge technology to manage blood sugar and enhance well-being
Semaglutide tricks your stomach to feel fuller and more satisfied; may be ineffective after withdrawl
A solution to reduce both antibiotic usage and antimicrobial resistance
NICE recommends Sleepio as a better alternative for habit-forming sleeping pills
Robotic assistance in cancer surgery could be far more beneficial than previously thought
Waist-to-height ratio could identify people at higher health risks
Libmeldy is life-saving gene therapy now available for use in England
Potential gene silencing approach in porphyria and possibly for many other diseases in the future
The amount we consume is more important than the amount we spend on what we thought is better
This life-changing new gene therapy will halt sight loss and improve vision
Needs to identify those who will respond to treatment before starting immunotherapy
Gene therapy presents injecting the healthy gene directly in the eye to produce working protein
Encouraging physical activity in the workplace will lead to having more productive employees
People with the highest risk of developing type 2 diabetes are being prioritised for places on NH...
In 2013, the British HIV Association recommended that patients be offered an HIV test on registra...
New NICE guidance warn that any tan is bad for you due to risk of skin cancer. Existing tan prov...